Volume defect of surgical incision line.
Conditions
Interventions
Intervention group: Suspension of Human Decellularized Amniotic Membrane Powder.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Female patients who grant informed consent to perform the procedure Patients who are able to understand the goals and potential risks of the study and sign a written consent to enter the study. If people are not able to read and write, the goals and risks are explained to them orally and the informed consent form would be completed by a third party on their behalf. Patients who have incision line volume defect
Exclusion criteria
Exclusion criteria: Current daily smokers People with autoimmune diseases People suffering from viral immunodeficiency virus or any defect in the immune system People with a history of thrombocytopenia, mast cell activation syndrome, active infection or carcinoma Areas of the cut line that are infected or have dehiscence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Injection site volume. Timepoint: Weeks 1, 4, and 12. Method of measurement: 3D imaging.;Adverse effects. Timepoint: Weeks 1, 4, and 12. Method of measurement: Patient expression and clinician evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hassan Niknejad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed